Prognostic and predictive significance of inflammatory markers in patients with locally advanced unresectable and metastatic pancreatic cancer treated with first-line chemotherapy FOLFIRINOX or Gemcitabine/Nabpaclitaxel / Maria Novisedlakova ... [et al.]. Bratislavské lekárske listy Vol. 125, no. 11 (2024), s. 745-758